We are live on ! Find out more
CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

Back to rankings

73 hedge funds and large institutions have $23.1M invested in Carisma Therapeutics in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 23 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.4% less ownership

Funds ownership: 1.11% → 0.71% (-0.4%)

10% less call options, than puts

Call options by funds: $1.31M | Put options by funds: $1.45M

13% less funds holding

Funds holding: 84 → 73 (-11)

22% less capital invested

Capital invested by funds: $29.5M → $23.1M (-$6.48M)

38% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 24

43% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 23

Holders
73
Holders Change
-11
Holders Change %
-13.1%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
13
Reduced
23
Closed
24
Calls
$1.31M
Puts
$1.45M
Net Calls
-$142K
Net Calls Change
+$46K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.53M
2
E
Ergoteles
New York
+$566K
3
Morgan Stanley
Morgan Stanley
New York
+$426K
4
PFMU
Privium Fund Management (UK)
United Kingdom
+$190K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$97.2K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$5.32M
2
N
Nuveen
North Carolina
-$3.11M
3
State Street
State Street
Massachusetts
-$2.1M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.12M
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
76
American International Group
New York
– -$60K -4,997 Closed
SO
77
STRS Ohio
Ohio
– -$57K -4,795 Closed
California State Teachers Retirement System (CalSTRS)
78
California State Teachers Retirement System (CalSTRS)
California
– -$53K -4,382 Closed
State Board of Administration of Florida Retirement System
79
State Board of Administration of Florida Retirement System
Florida
– -$52K -4,328 Closed
VOYA Investment Management
80
VOYA Investment Management
Georgia
– -$50K -4,178 Closed
Los Angeles Capital Management
81
Los Angeles Capital Management
California
– -$44K -3,633 Closed
Invesco
82
Invesco
Georgia
– -$43K -3,590 Closed
First Manhattan
83
First Manhattan
New York
– -$37K -3,100 Closed
Principal Financial Group
84
Principal Financial Group
Iowa
– -$35K -2,962 Closed
Allspring Global Investments
85
Allspring Global Investments
North Carolina
– -$30K -2,501 Closed
AB
86
Amalgamated Bank
New York
– -$20K -1,639 Closed
Barclays
87
Barclays
United Kingdom
– -$19K -1,634 Closed
Legal & General Group
88
Legal & General Group
United Kingdom
– -$15K -1,295 Closed
MAM
89
Meeder Asset Management
Ohio
– -$12K -911 Closed
Royal Bank of Canada
90
Royal Bank of Canada
Ontario, Canada
– -$7.87K -688 -98%
AIP
91
Ameritas Investment Partners
Nebraska
– -$8K -670 Closed
Prudential Financial
92
Prudential Financial
New Jersey
– -$7K -584 Closed
Mackenzie Financial
93
Mackenzie Financial
Ontario, Canada
– -$7K -539 Closed
CAL
94
Capital Advisors Ltd
Ohio
– +$92 +8 New
CG
95
Cutler Group
California
– +$412 +36 +720%
1 2 3
4

CARM Hedge Fund Activity: Q2 2022 in Review

73 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Carisma Therapeutics (CARM) for Q2 2022, worth a combined $23.1M — down 22% from $29.5M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of CARM and 15 opened new positions — a net loss of 9 holders — while 23 trimmed existing stakes and 13 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $1.53M. The largest seller was BlackRock, cutting an estimated $5.32M.

  • 73 institutional investors held Carisma Therapeutics (CARM) as of Q2 2022, down from 84 in Q1 2022.
  • Funds reported $23.1M of Carisma Therapeutics stock for Q2 2022, down 22% quarter-over-quarter.
  • 15 funds opened new Carisma Therapeutics positions in Q2 2022 and 24 closed out, a net change of -9 holders.
  • The largest Carisma Therapeutics buyer in Q2 2022 was Millennium Management, an estimated $1.53M added.
  • The largest Carisma Therapeutics seller in Q2 2022 was BlackRock, an estimated $5.32M sold.

Based on aggregated 13F filings for Q2 2022.